Literature DB >> 2784981

Tertiary structure of human complement component C5a in solution from nuclear magnetic resonance data.

E R Zuiderweg1, D G Nettesheim, K W Mollison, G W Carter.   

Abstract

The tertiary structure for the region 1-63 of the 74 amino acid human complement protein C5a in solution was calculated from a large number of distance constraints derived from nuclear Overhauser effects with an angular distance geometry algorithm. The protein consists of four helices juxtaposed in an approximately antiparallel topology connected by peptide loops located at the surface of the molecule. The structures obtained for the helices are compatible with alpha-helical hydrogen-bonding patterns, which provides an explanation for the observed slow solvent exchange kinetics of the amide protons in these peptide regions. In contrast to the peptide region 1-63, no defined structure could be assigned to the C-terminal region 64-74, which increasingly acquires dynamic random coil characteristics as the end of the peptide chain is approached. An average root-mean-square deviation of 1.6 A was obtained for the alpha-carbons of the first 63 residues in the calculated ensemble of C5a structures, while the alpha-helices were determined with an average root-mean-square deviation of 0.8 A for the alpha-carbons. A comparison between the solution structure of C5a and the crystal structure of the functionally related C3a protein, as well as inferences for the interaction of C5a with its receptor on polymorphonuclear leukocytes, is discussed.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2784981     DOI: 10.1021/bi00427a025

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  20 in total

1.  Structure of the streptococcal cell wall C5a peptidase.

Authors:  C Kent Brown; Zu-Yi Gu; Yury V Matsuka; Sai S Purushothaman; Laurie A Winter; P Patrick Cleary; Stephen B Olmsted; Douglas H Ohlendorf; Cathleen A Earhart
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-12       Impact factor: 11.205

Review 2.  C4a: An Anaphylatoxin in Name Only.

Authors:  Scott R Barnum
Journal:  J Innate Immun       Date:  2015-02-06       Impact factor: 7.349

3.  The predictive accuracy of secondary chemical shifts is more affected by protein secondary structure than solvent environment.

Authors:  Marie-Laurence Tremblay; Aaron W Banks; Jan K Rainey
Journal:  J Biomol NMR       Date:  2010-03-06       Impact factor: 2.835

4.  Solution structure of a unique C5a semi-synthetic antagonist: implications in receptor binding.

Authors:  X Zhang; W Boyar; N Galakatos; N C Gonnella
Journal:  Protein Sci       Date:  1997-01       Impact factor: 6.725

5.  Antagonistic peptides against human anaphylatoxin C5a.

Authors:  Y Kaneko; N Okada; L Baranyi; T Azuma; H Okada
Journal:  Immunology       Date:  1995-09       Impact factor: 7.397

6.  Two-site binding of C5a by its receptor: an alternative binding paradigm for G protein-coupled receptors.

Authors:  S J Siciliano; T E Rollins; J DeMartino; Z Konteatis; L Malkowitz; G Van Riper; S Bondy; H Rosen; M S Springer
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-15       Impact factor: 11.205

7.  Cloning and functional expression of the canine anaphylatoxin C5a receptor. Evidence for high interspecies variability.

Authors:  J J Perret; E Raspe; G Vassart; M Parmentier
Journal:  Biochem J       Date:  1992-12-15       Impact factor: 3.857

8.  Primary structure and functional characterization of rat C5a: an anaphylatoxin with unusually high potency.

Authors:  L Cui; D F Carney; T E Hugli
Journal:  Protein Sci       Date:  1994-08       Impact factor: 6.725

9.  The pharmacophore of the human C5a anaphylatoxin.

Authors:  M J Toth; L Huwyler; W C Boyar; A F Braunwalder; D Yarwood; J Hadala; W O Haston; M A Sills; B Seligmann; N Galakatos
Journal:  Protein Sci       Date:  1994-08       Impact factor: 6.725

10.  The structure of OMCI, a novel lipocalin inhibitor of the complement system.

Authors:  Pietro Roversi; Olga Lissina; Steven Johnson; Nurfilza Ahmat; Guido C Paesen; Kerstin Ploss; Wilhelm Boland; Miles A Nunn; Susan M Lea
Journal:  J Mol Biol       Date:  2007-03-30       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.